CONGRESS ASSET MANAGEMENT CO - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2024. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
CONGRESS ASSET MANAGEMENT CO ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q3 2015$10,948,000
-20.0%
61,374
-0.3%
0.28%
-28.4%
Q2 2015$13,678,000
+12.8%
61,571
+0.9%
0.39%
+35.4%
Q1 2015$12,121,000
+37.0%
61,026
-1.3%
0.29%
+29.3%
Q4 2014$8,848,000
+11.9%
61,826
+2.6%
0.22%
+10.8%
Q3 2014$7,910,000
+10.0%
60,288
+5.7%
0.20%
+10.9%
Q2 2014$7,194,000
-4.4%
57,037
-0.1%
0.18%
-2.7%
Q1 2014$7,524,000
+1.1%
57,071
-10.0%
0.19%
-3.6%
Q4 2013$7,444,000
+7.1%
63,409
-4.8%
0.20%0.0%
Q3 2013$6,949,000
+25.4%
66,608
+3.4%
0.20%
+18.9%
Q2 2013$5,543,00064,3900.16%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q2 2024
NameSharesValueWeighting ↓
Bruce & Co., Inc. 550,000$3,833,5001.26%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders